Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -323.71% is 105% below its 2-year average of -158.01%, near the low end of its 2-year range (-323.71%–-83.86%).
As of the fiscal period ended Tuesday, June 30, 2026. 95.55% below its 12-month average of -165.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -323.71%.
RETURN ON INVESTED CAPITAL (ROIC)
-323.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-165.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-95.55%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-807.78%
vs the sector median at left
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Return on Invested Capital (ROIC)
-323.71%
TTM Avg
-165.54%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-121.58%
3Y Avg
-92.03%
5Y Avg
-78.85%
Market Cap
$10.06M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$10.21M
Return on Invested Capital (ROIC)
-95.42%
TTM Avg
-108.10%
3Y Avg
-72.41%
5Y Avg
-59.15%
Market Cap
$9.86M
Return on Invested Capital (ROIC)
-55.13%
TTM Avg
-99.85%
3Y Avg
-167.97%
5Y Avg
-308.25%
Market Cap
$9.83M
Return on Invested Capital (ROIC)
-183.45%
TTM Avg
-213.20%
3Y Avg
-179.79%
5Y Avg
-169.02%
Market Cap
$10.45M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$9.75M
Return on Invested Capital (ROIC)
-215.61%
TTM Avg
-191.09%
3Y Avg
-141.72%
5Y Avg
-179.96%
Market Cap
$9.71M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | -323.71% | -165.54% | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | -227.67% | -121.58% | -92.03% | -78.85% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -269.16% | -387.93% | -400.47% | -400.47% |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -95.42% | -108.10% | -72.41% | -59.15% |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -55.13% | -99.85% | -167.97% | -308.25% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -183.45% | -213.20% | -179.79% | -169.02% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | -240.64% | -174.03% | -198.05% | -242.53% |
| MetaVia Inc. (MTVA)vs › | $9.75M | -215.61% | -191.09% | -141.72% | -179.96% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | -59.35% | -68.11% | -104.39% | -133.77% |
| Pluri Inc. (PLUR)vs › | $10.68M | -127.37% | -96.60% | -79.17% | -74.39% |
ROIC
-323.7%
ROE
-310.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -323.71% |
| 2026-03-31 | -202.25% |
| 2025-12-31 | -117.83% |
| 2025-09-30 | -100.05% |
| 2025-06-30 | -83.86% |
| 2025-03-31 | -125.15% |
| 2024-12-31 | -133.80% |
| 2024-09-30 | -168.05% |
| 2024-06-30 | -167.37% |
